GlassScriptPhysician profile
Tarun Dasari
NPI 1265572366
$2,013.44
in general payments reported to CMS, 2019-2025
24 companies · $430 in 2025
The $430 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2021: $99.99 · 2022: $94.84 · 2023: $284 · 2024: $466 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,179.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $593.47 | 2019 | |
| Medtronic, INC. | $264.84 | 2022-2025 | Micra, Linq II, Cobalt Dr Mri Surescan |
| Astrazeneca Pharmaceuticals LP | $225.98 | 2021-2025 | Wainua, Farxiga, Tezspire |
| Pfizer INC. | $217.50 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $89.53 | 2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $78.44 | 2023-2025 | |
| Baxter Healthcare | $74.80 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Amgen INC. | $65.73 | 2024-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $63.57 | 2023-2024 | Camzyos |
| Philips North America LLC | $53.39 | 2024 | (Ck4) Mcot |
| Pulmonx Corporation | $37.77 | 2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Janssen Pharmaceuticals, INC | $35.22 | 2023-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.78 | 2019-2025 | Lifevest |
| Lantheus Medical Imaging, INC. | $24.10 | 2019 | |
| Irhythm Technologies, INC. | $20.32 | 2023 | Zio Xt Patch |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.19 | 2024 | Jardiance |
| Stryker Corporation | $18.37 | 2024 | N/A |
| Insmed, INC. | $18.00 | 2025 | Arikayce |
| Alnylam Pharmaceuticals INC. | $17.40 | 2019 | |
| Cashflow Solutions, LLC | $16.46 | 2023 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Merck Sharp & Dohme LLC | $15.60 | 2023 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Scpharmaceuticals INC. | $14.82 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $14.16 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarun Dasari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.